Theratechnologies Inc. (THTX)
NASDAQ: THTX · Real-Time Price · USD
1.720
+0.060 (3.61%)
At close: Jan 14, 2025, 4:00 PM
1.800
+0.080 (4.65%)
After-hours: Jan 14, 2025, 5:12 PM EST
Theratechnologies Employees
Theratechnologies had 103 employees as of November 30, 2023. The number of employees decreased by 41 or -28.47% compared to the previous year.
Employees
103
Change (1Y)
-41
Growth (1Y)
-28.47%
Revenue / Employee
$818,602
Profits / Employee
-$30,660
Market Cap
78.78M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
THTX News
- 5 days ago - Theratechnologies Provides Update on EGRIFTA SV® Supply - GlobeNewsWire
- 27 days ago - Theratechnologies Announces Filing of FDA Prior Approval Supplement for EGRIFTA SV® Manufacturing Environment - GlobeNewsWire
- 5 weeks ago - Theratechnologies Receives March 2025 PDUFA Goal Date for Updated Tesamorelin F8 Formulation sBLA - GlobeNewsWire
- 5 weeks ago - Theratechnologies Announces Preliminary Tolerability and Efficacy Data from Phase 1b, Dose-Ranging Trial of Sudocetaxel Zendusortide in Patients with Advanced Ovarian Cancer - GlobeNewsWire
- 5 weeks ago - Theratechnologies Announces Exclusive Licensing Agreement with Ionis to Commercialize Olezarsen and Donidalorsen in Canada - GlobeNewsWire
- 6 weeks ago - Theratechnologies Announces Resumed Production of EGRIFTA SV® - GlobeNewsWire
- 6 weeks ago - Theratechnologies Secures up to $75 Million in New Credit Facilities with TD Bank and Investissement Québec - GlobeNewsWire
- 7 weeks ago - Theratechnologies Submits Updated Tesamorelin F8 Formulation sBLA for FDA Review - GlobeNewsWire